Jędrys, Wiktoria
Leśniak, Aleksandra
Borkowska, Aneta http://orcid.org/0000-0003-3201-3693
Rutkowski, Piotr http://orcid.org/0000-0002-8920-5429
Sobczuk, Paweł http://orcid.org/0000-0002-4103-1626
Article History
Received: 25 July 2023
Accepted: 29 September 2023
First Online: 23 November 2023
Declarations
:
: Pawel Sobczuk has received travel grants from MSD, BMS, Roche, Novartis, and Pierre Fabre; honoraria for lectures from Swixx BioPharma, BMS, Gilead and Sandoz; honoraria for Advisory Boards from Sandoz; is a stock owner of Celon Pharma; Non-financial interests: European Society of Medical Oncology—Officer; Polish Society of Clinical Oncology—Member of Board of Directors. Piotr Rutkowski has received honoraria for lectures from BMS, Merck, MSD, Novartis, Pierre Fabre, Sanofi; honoraria for Advisory Boards from Blueprint Medicines, BMS, Merck, MSD, Novartis, Pierre Fabre, Sanofi; Institutional funding support from BMS and Pfizer; Non-financial interests: ASCO—Officer, Polish Society of Surgical Oncology—Member of Board of Directors, Polish Oncological Society—President. Wiktoria Jędrys, Aleksandra Leśniak and Aneta Borkowska declare no conflict of interest.